drugset
drugset / Trial / NCT04174911

A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.

NCT04174911 ↗

Phase 1/2 Withdrawn Breath of Life International Pharma Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Phase 2a, Single-center, randomized, double-blind, placebo-controlled study, in 80 subjects diagnosed with Endometriosis, stage 2-4

Timeline

Start
2019-01
Primary completion
2020-12
Completion
2020-12

Outcome

Outcome not reported

Stopped: “covid 19”

Drugs

EvaluationDrugModalityDoseRoute
Subject BOL-DP-o-08 Unknown — Other

Indications

endometriosis